Literature DB >> 19283881

Growing role of CD40 ligand gene transfer therapy in the management of systemic malignancies besides hepatocellular carcinomas.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283881      PMCID: PMC2650036          DOI: 10.1631/jzus.B0950001

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


× No keyword cloud information.
  6 in total

1.  Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.

Authors:  Jian-Qing Wu; Wei-Hong Zhao; Yan Li; Bei Zhu; Kai-Sheng Yin
Journal:  Virology       Date:  2007-08-06       Impact factor: 3.616

2.  Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.

Authors:  S Serba; J Schmidt; N Wentzensen; E Ryschich; A Märten
Journal:  Gut       Date:  2007-08-03       Impact factor: 23.059

3.  Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.

Authors:  K Tomihara; K Kato; Y Masuta; K Nakamura; H Uchida; K Sasaki; T Tanaka; J Huang; H Hiratsuka; H Hamada
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

4.  Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model.

Authors:  Helena Dzojic; Angelica Loskog; Thomas H Tötterman; Magnus Essand
Journal:  Prostate       Date:  2006-06-01       Impact factor: 4.104

Review 5.  Adenoviral gene therapy for pancreatic cancer: where do we stand?

Authors:  Koert F D Kuhlmann; Dirk J Gouma; John G Wesseling
Journal:  Dig Surg       Date:  2008-07-17       Impact factor: 2.588

6.  Cationic liposome-mediated transfection of CD40 ligand gene inhibits hepatic tumor growth of hepatocellular carcinoma in mice.

Authors:  Yong-fang Jiang; Jing Ma; Yan He; Yong-hong Zhang; Yun Xu; Guo-zhong Gong
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.